480
Views
4
CrossRef citations to date
0
Altmetric
Research Article

In vitro reactivation of trichlorfon-inhibited butyrylcholinesterase using HI-6, obidoxime, pralidoxime and K048

, &
Pages 680-683 | Received 11 Mar 2008, Accepted 19 May 2008, Published online: 01 Jun 2009

Figures & data

Figure 1. Reactivators used.

Figure 1.  Reactivators used.

Figure 2. Semilogarithmic expression of reactivation efficacy. Percent of reactivation (R) vs. logarithm of reactivator molar concentration (final on plate). Reactivation was realized after 0.5 h incubation of trichlorfon with butyrylcholinesterase. Error bars indicate standard deviation (n = 4).

Figure 2.  Semilogarithmic expression of reactivation efficacy. Percent of reactivation (R) vs. logarithm of reactivator molar concentration (final on plate). Reactivation was realized after 0.5 h incubation of trichlorfon with butyrylcholinesterase. Error bars indicate standard deviation (n = 4).

Figure 3. Semilogarithmic expression of reactivation efficacy. The meaning of symbols is the same as in . Data were obtained for reactivation after 1 h of incubation of butyrylcholinesterase with trichlorfon.

Figure 3.  Semilogarithmic expression of reactivation efficacy. The meaning of symbols is the same as in Figure 2. Data were obtained for reactivation after 1 h of incubation of butyrylcholinesterase with trichlorfon.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.